Minocycline is a useful adjuvant therapy for pemphigus

Australasian Journal of Dermatology

Volumn 37, Issue 2, 1996, Pages 93-95

  Gaspar, Zoran S ^a   Walkden, Valerie ^b   Wojnarowska, Fenella ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

Pemphigus foliaceus; Pemphigus vulgaris; Steroid sparing

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG COMBINATION; HUMAN; MIDDLE AGED; PEMPHIGUS; REMISSION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; DRUG COMBINATIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MINOCYCLINE; PEMPHIGUS; PREDNISOLONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 0030144786     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1996.tb01013.x     Document Type: Article

References (20)

1. Korman N. Pemphigus. J. Am. Acad. Dermatol. 1988; 18: 1219-38.
2. Gellis S, Glass FA. Pemphigus. A survey of one hundred and seventy-six patients admitted to Bellvue Hospital from 1911 to 1942. Arch. Dermatol. 1941; 44: 321-6.
3. Combes FC, Canizares O. Pemphigus vulgaris. A clinicopathological study of one hundred cases. Arch. Dermatol. 1950; 62: 786-802.
4. Eller JJ, Kest LH. Pemphigus, a report of seventy-one cases. Arch. Dermatol. 1960; 82: 717-24.
5. Lever WF. Pemphigus and Pemphigoid, Springfield, IL: Charles C Thomas, 1965.
6. Hirone T. Pemphigus: a survey of 85 patients between 1970 and 1974. J. Dermatol. 1978; 5: 43-7.
7. Hielanen J, Salo OP. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta Derm. Venerol. (Stockh.) 1982; 62: 491-6.
8. Savin JA. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid. Br. J. Dermatol. 1981; 104: 415-20.
9. Lever WF, White H. Treatment of pemphigus vulgaris with corticosteroids: Results obtained in 46 patients over a period of 11 years. Arch. Dermatol. 1963; 87: 12-26.
10. Piamphongsant T, Ophaswongse S. Treatment of pemphigus. Int. J. Dermatol. 1991; 50: 139-46.
11. Thornfeldt OR, Menkes AW. Bullous pemphigoid controlled by tetracycline. J. Am. Acad. Dermatol. 1987; 16: 305-10.
12. Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalised bullous pemphigoid with oral tetracyclines. J. Am. Acad. Dermatol. 1993; 28: 74-7.
13. Poskitt L, Wojnarowska F. Minimizing cicatricial pemphigoid orodynia with minocycline. Br. J. Dermatol. 1995; 132: 784-9.
14. Mallon E, Wojnarowska F. Cicatricial pemphigoid presenting with unusual palmar involvement, successfully treated with a combination of nicotinamide and tetracycline. Clin. Exp. Dermatol. 1994; 19: 526-30.
15. Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin. Exp. Dermatol. 1995; 20; 258-9.
16. Berk NA, Lorincz AL. The treatment of bullous pemphigoid with tetracycline and nicotinamide. Arch. Dermatol. 1986; 122: 670-4.
17. Fiveson DP, Breneman DL, Rosen GB et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch. Dermatol. 1994; 130: 753-8.
18. Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: A review of 13 cases. J. Am. Acad. Dermatol. 1993; 28: 998-1000.
19. Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses to tetracycline analogues. Clin. Exp. Immunol 1979; 35: 443-6.
20. Joint Formulary Committee. British National Formulary, no. 29. London: British Medical Association and The Pharmaceutical Press, 1995.